Lily receives conditional approval for Cymbalta

09/18/2002 | Forbes

The FDA has given Eli Lilly conditional approval to introduce an antidepressant. The final approval is contingent on Eli Lilly rectifying problems at its manufacturing plants. The company behind Prozac lost its patent on the blockbuster drug last year, which made up $2 billion of Eli Lilly's sales.

View Full Article in:

Forbes

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC